| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.ATV.13.8.1139 |
| P698 | PubMed publication ID | 8343489 |
| P50 | author | Eric Boerwinkle | Q28050857 |
| P2093 | author name string | A M Gotto | |
| W Patsch | |||
| R Hutchinson | |||
| S A Brown | |||
| C E Davis | |||
| J Morrisett | |||
| P433 | issue | 8 | |
| P304 | page(s) | 1139-1158 | |
| P577 | publication date | 1993-08-01 | |
| P1433 | published in | Arteriosclerosis and thrombosis : a journal of vascular biology | Q27709770 |
| P1476 | title | Plasma lipid, lipoprotein cholesterol, and apoprotein distributions in selected US communities. The Atherosclerosis Risk in Communities (ARIC) Study | |
| P478 | volume | 13 |
| Q73466877 | An application of apo(a) isoforms for the clinical assessment of Lp(a) |
| Q37727490 | An approach to the etiology of metabolic syndrome |
| Q36675401 | Analysis of angiographic trial data in women. |
| Q33902065 | Association analysis of 33 lipoprotein candidate genes in multi-generational families of African ancestry. |
| Q37628998 | Association of body mass index and abdominal adiposity with atherogenic lipid profile in Nigerians with type 2 diabetes and/or hypertension |
| Q78067776 | Associations of obesity markers, insulin, and sex hormones with HDL-cholesterol levels in Turkish and German individuals |
| Q36383677 | Biogeographic ancestry, self-identified race, and admixture-phenotype associations in the Heart SCORE Study |
| Q35915957 | Causal Role of Alcohol Consumption in an Improved Lipid Profile: The Atherosclerosis Risk in Communities (ARIC) Study |
| Q30470928 | Cross-sectional and longitudinal changes in total and high-density-lipoprotein cholesterol levels over a 20-year period in elderly men: the Honolulu Heart Program |
| Q36496770 | Determinants of plasma apolipoprotein A-V and APOA5 gene transcripts in humans |
| Q46114213 | Did grandma give you heart disease? The new battle against coronary artery disease |
| Q45335769 | Distribution of lipids in 8,500 men with coronary artery disease. Department of Veterans Affairs HDL Intervention Trial Study Group |
| Q43748764 | Effect of hormone replacement therapy on lipids in perimenopausal and early postmenopausal women |
| Q36975580 | Effect of obesity on the plasma lipoprotein subclass profile in normoglycemic and normolipidemic men and women |
| Q73409238 | Effects of menopause and obesity on lipid profiles in middle-aged Taiwanese women: the Chin-Shan Community Cardiovascular Cohort Study |
| Q43913015 | Effects of menopause on intraindividual changes in serum lipids, blood pressure, and body weight--the Chin-Shan Community Cardiovascular Cohort study |
| Q37392489 | Elevated lipoprotein(a) levels predict cardiovascular disease in type 2 diabetes mellitus: a 10-year prospective cohort study |
| Q35741878 | Established risk factors account for most of the racial differences in cardiovascular disease mortality |
| Q79346662 | Ethnic differences in hepatic lipase and HDL in Japanese, black, and white Americans: role of central obesity and LIPC polymorphisms |
| Q46187205 | Ethnicity effect on the serum lipid profile in persons with spinal cord injury |
| Q55405081 | Evaluation of the relationship between plasma lipids and abdominal aortic aneurysm: A Mendelian randomization study. |
| Q71808013 | Factors affecting fibrinolytic potential: cardiovascular fitness, body composition, and lipoprotein(a) |
| Q28069213 | Gender difference in oxidative stress: a new look at the mechanisms for cardiovascular diseases |
| Q29614897 | Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease |
| Q33753633 | Genome-wide association study identifies GPC5 as a novel genetic locus protective against sudden cardiac arrest |
| Q43889901 | HDL particle size: a marker of the gender difference in the metabolic risk profile |
| Q36966320 | HDL-cholesterol and the incidence of lung cancer in the Atherosclerosis Risk in Communities (ARIC) study |
| Q51552490 | Hypercholesterolemia and Dyslipidemia. |
| Q51537186 | Hypercholesterolemia and Dyslipidemia: Issues for the Clinician. |
| Q90394889 | Impact of Acipimox Therapy on Free Fatty Acid Efflux and Endothelial Function in the Metabolic Syndrome: A Randomized Trial |
| Q37623696 | Influence of vanadium on serum lipid and lipoprotein profiles: a population-based study among vanadium exposed workers |
| Q55462786 | Lipid profile and plasma atherogenic index in postmenopausal osteoporosis. |
| Q43729975 | Lipoprotein (a) level in the population in Taiwan: relationship to sociodemographic and atherosclerotic risk factors |
| Q34027241 | Lipoprotein(a) and coronary heart disease risk |
| Q24629580 | Lipoprotein(a), hormone replacement therapy, and risk of future cardiovascular events |
| Q37392497 | Lipoprotein(a): a not-so-well-known risk factor for the development of cardiovascular disease in patients with type 2 diabetes mellitus |
| Q73009111 | Lp(a) concentrations are related to plasma lipid concentrations |
| Q43687592 | Metabolic disorders contribute to subclinical coronary atherosclerosis in patients with coronary calcification. |
| Q73289007 | Monthly intra-individual variation in lipoprotein(a) in 22 normal subjects over 12 months |
| Q46166109 | Multiple lipid scoring system for prediction of coronary heart disease risk: application to African Americans |
| Q35739667 | Niacin extended-release/simvastatin combination therapy produces larger favorable changes in high-density lipoprotein particles than atorvastatin monotherapy |
| Q35559549 | Plasma lipoprotein concentrations in ethnic populations |
| Q40458696 | Postmenopausal Hormone-Replacement Therapy and Cardiovascular Risk |
| Q46229949 | Premenopausal black women have more risk factors for coronary heart disease than white women |
| Q79712804 | Quantitative effects of common genetic variations in the 3'UTR of the human LDL-receptor gene and their associations with plasma lipid levels in the Atherosclerosis Risk in Communities study |
| Q90607442 | Reference values for laboratory tests of cholesterol, glycosylated hemoglobin and creatinine of the Brazilian adult population |
| Q28344927 | Relation of Apo(a) size to carotid atherosclerosis in an elderly multiethnic population |
| Q33640880 | Relationship of alcohol consumption and type of alcoholic beverage consumed with plasma lipid levels: differences between Whites and African Americans of the ARIC study |
| Q44465381 | Relationship of lipoprotein(a) with intimal medial thickness of the carotid artery in Type 2 diabetic patients in south India |
| Q28254058 | Serum LP(a) levels in African aboriginal Pygmies and Bantus, compared with Caucasian and Asian population samples |
| Q52204742 | Serum sialic acid and sialoglycoproteins in asymptomatic carotid artery atherosclerosis. ARIC Investigators. Atherosclerosis Risk in Communities. |
| Q41071705 | Significance of apolipoproteins for structure, function, and classification of plasma lipoproteins |
| Q34991463 | Statins and menopause |
| Q37305708 | The association of cell cycle checkpoint 2 variants and kidney function: findings of the Family Blood Pressure Program and the Atherosclerosis Risk In Communities study |
| Q24540378 | The concept of race and health status in America |
| Q51566961 | The effect of hormone replacement therapy alone and in combination with simvastatin on plasma lipids of hypercholesterolemic postmenopausal women with coronary artery disease. |
| Q38233052 | The expanding role of lipoprotein apheresis in the treatment of raised lipoprotein(a) in ischaemic heart disease and refractory angina |
| Q74238705 | The frequency of the cholesteryl ester transfer protein-TaqI B2 allele is lower in African Americans than in Caucasians |
| Q77228943 | The relationship between lipids/lipoproteins and atherosclerosis in African Americans and whites: the Atherosclerosis Risk in Communities Study |
| Q46255694 | The relationship in African-Americans of sex differences in insulin-mediated suppression of nonesterified fatty acids to sex differences in fasting triglyceride levels |
| Q48033046 | Use of apolipoprotein parameters and endpoints in drug development and approval processes |
| Q60614528 | Usefulness of Lipoprotein-Associated Phospholipase A Activity and C-Reactive Protein in Identifying High-Risk Smokers for Atherosclerotic Cardiovascular Disease (from the Atherosclerosis Risk in Communities Study) |
| Q73222138 | Usefulness of brachial artery reactivity to isometric handgrip exercise in identifying patients at risk and with coronary artery disease |
| Q52897432 | [Estrogens for prevention of coronary heart disease?]. |
Search more.